×
About 6,106 results

ALLMedicine™ C-peptide Center

Research & Reviews  3,003 results

Low-dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up Report.
https://doi.org/10.2337/db20-1103
Diabetes Lin A, Mack JA et. al.

Feb 26th, 2021 - Previously, we demonstrated low-dose anti-thymocyte globulin (ATG) and granulocyte colony stimulating factor (GCSF) immunotherapy preserved C-peptide for two years in a pilot study of subjects with established type 1 diabetes (n=25). Herein, we ev...

Newborn Adiposity and Cord Blood C-Peptide as Mediators of the Maternal Metabolic Envir...
https://doi.org/10.2337/dc20-2398
Diabetes Care; Josefson JL, Scholtens DM et. al.

Feb 23rd, 2021 - Excessive childhood adiposity is a risk factor for adverse metabolic health. The objective was to investigate associations of newborn body composition and cord C-peptide with childhood anthropometrics and explore whether these newborn measures med...

Role of umbilical cord C-peptide levels in early prediction of hypoglycemia in infants ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888149
BMC Pediatrics; Saber AM, Mohamed MA et. al.

Feb 18th, 2021 - Until now, diabetes during pregnancy has been associated with a high risk of maternal, fetal, and neonatal morbidities and mortalities. The main aim of this study was to evaluate the risk factors of hypoglycemia in infants of diabetic mothers (IDM...

Glucose tolerance in patients with and without type 2 diabetes mellitus during hemodial...
https://doi.org/10.1016/j.diabres.2021.108694
Diabetes Research and Clinical Practice; Niemczyk L, Schneditz D et. al.

Feb 11th, 2021 - The disposal of a glucose bolus was studied to identify glucose metabolism in patients with and without type 2 diabetes mellitus (T2DM) during their regular hemodialysis (HD) treatment. Plasma glucose, insulin, and c-peptide concentrations were me...

Prognostic bioindicators in severe COVID-19 patients.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843114
Cytokine Bergantini L, Bargagli E et. al.

Feb 6th, 2021 - Severe acute respiratory syndrome caused by novel coronavirus 2 (SARS-CoV-2) emerged in Wuhan (China) in December 2019. Here we evaluated a panel of biomarkers to phenotype patients and to define the role of immuno-inflammatory mediators as biomar...

see more →

Guidelines  1 results

Human postprandial responses to food and potential for precision nutrition
https://www.nature.com/articles/s41591-020-0934-0

Metabolic responses to food influence risk of cardiometabolic disease, but large-scale high-resolution studies are lacking. We recruited n = 1,002 twins and unrelated healthy adults in the United Kingdom to the PREDICT 1 study and assessed postpra...

see more →

Clinicaltrials.gov  3,039 results

Low-dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up Report.
https://doi.org/10.2337/db20-1103
Diabetes Lin A, Mack JA et. al.

Feb 26th, 2021 - Previously, we demonstrated low-dose anti-thymocyte globulin (ATG) and granulocyte colony stimulating factor (GCSF) immunotherapy preserved C-peptide for two years in a pilot study of subjects with established type 1 diabetes (n=25). Herein, we ev...

Newborn Adiposity and Cord Blood C-Peptide as Mediators of the Maternal Metabolic Envir...
https://doi.org/10.2337/dc20-2398
Diabetes Care; Josefson JL, Scholtens DM et. al.

Feb 23rd, 2021 - Excessive childhood adiposity is a risk factor for adverse metabolic health. The objective was to investigate associations of newborn body composition and cord C-peptide with childhood anthropometrics and explore whether these newborn measures med...

Role of umbilical cord C-peptide levels in early prediction of hypoglycemia in infants ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888149
BMC Pediatrics; Saber AM, Mohamed MA et. al.

Feb 18th, 2021 - Until now, diabetes during pregnancy has been associated with a high risk of maternal, fetal, and neonatal morbidities and mortalities. The main aim of this study was to evaluate the risk factors of hypoglycemia in infants of diabetic mothers (IDM...

Glucose tolerance in patients with and without type 2 diabetes mellitus during hemodial...
https://doi.org/10.1016/j.diabres.2021.108694
Diabetes Research and Clinical Practice; Niemczyk L, Schneditz D et. al.

Feb 11th, 2021 - The disposal of a glucose bolus was studied to identify glucose metabolism in patients with and without type 2 diabetes mellitus (T2DM) during their regular hemodialysis (HD) treatment. Plasma glucose, insulin, and c-peptide concentrations were me...

Prognostic bioindicators in severe COVID-19 patients.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843114
Cytokine Bergantini L, Bargagli E et. al.

Feb 6th, 2021 - Severe acute respiratory syndrome caused by novel coronavirus 2 (SARS-CoV-2) emerged in Wuhan (China) in December 2019. Here we evaluated a panel of biomarkers to phenotype patients and to define the role of immuno-inflammatory mediators as biomar...

see more →

News  63 results

Fast Five Quiz: Type 2 Diabetes Key Aspects
https://reference.medscape.com/viewarticle/935538_4

Aug 17th, 2020 - According to the ADA, criteria for the diagnosis of diabetes includes any of the following: A fasting plasma glucose level ≥ 126 mg/dL (7 mmol/L); fasting is defined as no caloric intake for at least 8 hours A 2-hour plasma glucose level ≥ 200 mg/...

Some With Type 1 Diabetes Misdiagnosed; Call for Genetic Screening
https://www.medscape.com/viewarticle/915270

Jul 4th, 2019 - About a third of people who have lived with a diagnosis of type 1 diabetes for over 50 years still maintain detectable C-peptide production, and a small proportion have another form of diabetes that could signal their ability to come off insulin a...

Some With Type 1 Diabetes Misdiagnosed; Call for Genetic Screening
https://www.staging.medscape.com/viewarticle/915270

Jul 4th, 2019 - About a third of people who have lived with a diagnosis of type 1 diabetes for over 50 years still maintain detectable C-peptide production, and a small proportion have another form of diabetes that could signal their ability to come off insulin a...

C-Peptide Test Should Be the Norm After Type 1 Diabetes
https://www.medscape.com/viewarticle/910328

Mar 12th, 2019 - LIVERPOOL — C-peptide testing a few years after a diagnosis of type 1 diabetes should be a routine procedure as it can help pinpoint occasional patients who have been misdiagnosed and actually have type 2 diabetes or a monogenic form of the diseas...

Renal Denervation May Help With Glycemic Control
https://www.medpagetoday.com/cardiology/pci/76981

Dec 17th, 2018 - Aside from a modest benefit in hypertension, renal denervation may also help normalize glucose homeostasis, according to a research group in Germany. Six months after renal denervation, non-diabetic patients showed better insulin control through t...

see more →